Recruiting Xeroderma Pigmentosum Studies in Rochester
About Xeroderma Pigmentosum Clinical Trials in Rochester
Xeroderma pigmentosum is a rare genetic disorder characterized by extreme sensitivity to ultraviolet light, leading to very high risk of skin cancer and eye damage. It is caused by defects in DNA repair mechanisms. Management requires strict UV protection and vigilant cancer surveillance.
There are currently 2 xeroderma pigmentosum clinical trials recruiting participants in Rochester, MI. These studies are seeking a combined 47 participants. Research is being sponsored by Vironexis Biotherapeutics Inc., University of Rochester. Clinical trial participation is free and participants receive study-related medical care at no cost.
Xeroderma Pigmentosum Clinical Trials in Rochester — FAQ
Are there xeroderma pigmentosum clinical trials in Rochester?
Yes, there are 2 xeroderma pigmentosum clinical trials currently recruiting in Rochester, MI. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Rochester?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Rochester research site will contact you about next steps.
Are clinical trials in Rochester free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Rochester studies also compensate for your time and travel.
What xeroderma pigmentosum treatments are being tested?
The 2 active trials in Rochester are testing new therapies including novel drugs, biologics, and treatment approaches for xeroderma pigmentosum.
Data updated July 13, 2026 from ClinicalTrials.gov